Sinocell Pharmaceutical (002332.SZ) obtained the domestic production drug registration certificate for estradiol tablets.

Zhixun Finance APP News, Xianju Pharmaceutical (002332.SZ) announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for estradiol tablets, and the company's estradiol tablets have been approved for registration. The indications for estradiol tablets are related to diseases caused by estrogen deficiency and can also prevent osteoporosis.